SCHEMBL6236814

SCHEMBL6236814

CC(=O)NC[C@H]1CN(c2ccc3c(c2)CCCc2c(-c4ccc(O)cc4)n[nH]c2-3)C(=O)O1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.47
MAOB P27338 2/20 0.44
PTGS1 P23219 2/20 0.44
SDHA P31040 2/20 0.44
LMNA P02545 1/20 0.44
CALML3 P27482 1/20 0.44
CHEK1 O14757 6/20 0.41
SGK1 O00141 2/20 0.39
AKT1 P31749 2/20 0.39
AKT2 P31751 2/20 0.39
AKT3 Q9Y243 2/20 0.39
AURKA O14965 1/20 0.39
CSNK2A2 P19784 1/20 0.39
CSNK2B P67870 1/20 0.39
CSNK2A1 P68400 1/20 0.39
CHEK2 O96017 1/20 0.39
PRKCG P05129 1/20 0.39
MARK2 Q7KZI7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6236818 1.00 MAOA (0.47) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6237329 0.94 MAOA (0.46) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6237320 0.94 MAOA (0.46) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6237924 0.93 MAOA (0.51) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6237920 0.93 MAOA (0.51) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6237534 0.93 MAOA (0.48) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6237531 0.93 MAOA (0.48) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6240224 0.92 MAOA (0.46) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6240231 0.92 MAOA (0.46) MAOAMAOBPTGS1SDHALMNA
SCHEMBL6238898 0.92 MAOA (0.47) MAOAMAOBPTGS1SDHALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288273-A1 Antibacterial agents BOYER FREDERICK E JR 2005-12-29 US claimed
EP-1594865-A2 ANTIBACTERIAL AGENTS Warner-Lambert Company LLC (US) 2005-11-16 EP claimed
WO-2004069832-A2 ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY LLC (US) 2004-08-19 WO claimed
US-20050288273-A1 Antibacterial agents BOYER FREDERICK E JR 2005-12-29 US disclosed
EP-1594865-A2 ANTIBACTERIAL AGENTS Warner-Lambert Company LLC (US) 2005-11-16 EP disclosed
WO-2004069832-A2 ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY LLC (US) 2004-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288273-A1 Antibacterial agents MRPL21, RPN2, FBL MAOA 236/4885MAOB 221/4885PTGS1 810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.